WCG acquires biopharmaceutical consultancy Waife & Associates

12 November 2019 Consulting.us

The clinical division of WIRB-Copernicus Group (WCG) has acquired Waife & Associates (W&A), a management consultancy which provides solutions to clients operating within the biopharmaceutical clinical research sector.

W&A is a consulting firm which helps its clients increase the efficiency of clinical development by streamlining their organization, processes, and technology.

W&A will continue to operate as a standalone unit, and remain in its Needham, Massachusetts headquarters. Additionally, W&A founder Ronald S. Waife will take on the role of chief management consulting officer for WCG. Full financial details of the acquisition are undisclosed.

"We are greatly pleased to join WCG, which is demonstrating a true commitment to innovation and transformation in drug development," Waife said. "The possibilities this offers us to expand our contributions, and create new opportunities for new solutions, is very exciting to us."

WCG acquires biopharmaceutical consultancy Waife & Associates

W&A was founded in 1993. It has worked with more than 200 companies from its offices in the US and Europe. The firm is tech-forward and has long championed industry adoption of electronic data capture – the digital collection of data for clinical trials – and electronic clinical outcomes assessments, or eCOA, which leverages technology such as tablets to allow clinicians to quickly and directly report outcomes, thus giving them more detailed data.

WCG is the biopharmaceutical industry’s first clinical services organization. It offers a variety of services and solutions that increase the quality and efficiency of clinical research.

"With this acquisition, WCG has taken another important step toward its goal of providing comprehensive transformational services to those conducting clinical trials," Donald A. Deieso, PhD, executive chairman and CEO of WCG, said. "We have long recognized that research sites and sponsors universally need assistance in improving the speed and efficacy of their operational processes.

"We are excited to add W&A's unique expertise, perspective and skills to accelerate improvement in research enterprises. We look forward to expanding the breadth of their market impact and enabling them to draw on WCG's rich knowledgebase of data and resources to inform and enhance the operations of those who sponsor and conduct life-saving clinical research."


×